RBN Stock Chart & Stats
$1073.50
$0.00(0.00%)
At close: 4:00 PM EDT
$1073.50
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$1,056.60 - $1,572.05
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
$747.77B
Enterprise Value$41.15K
Total Cash (Recent Filing)$878.00M
Total Debt (Recent Filing)$10.16B
Price to Earnings (P/E)11.5
Beta-0.06
Next Earnings
Mar 03, 2027EPS Estimate
44.49Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)4.46
Shares Outstanding635,007,200
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.09
Price to Book (P/B)5.26
Price to Sales (P/S)2.87
P/FCF Ratio23.16
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$1,434.16Price Target Upside33.60% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering8
EPS Forecast (FY)0.78
Revenue Forecast (FY)$3.00B
Bulls Say, Bears Say
Bulls Say
Margin ImprovementReckitt's reported net margin ~22% and EBIT margin ~30% in 2025 indicate a durable uplift in profitability driven by pricing, mix and cost actions. Sustained higher margins improve free cash flow potential, support reinvestment and dividend capacity, and increase resilience to revenue volatility over the medium term.
Stronger Balance SheetA material reduction in debt-to-equity to ~0.13 meaningfully lowers financial risk and raises strategic optionality. Persistently low leverage supports continued shareholder returns, funds cost-program investments and cushions operational shocks, enhancing long-term financial flexibility if maintained.
Emerging Markets & InnovationSustained double-digit China growth and broad emerging market outperformance, combined with multiple successful product launches, indicate structural market-position strength and premiumization potential. This geographic and innovation momentum supports multi-quarter revenue resilience and diversification of growth drivers.
Bears Say
Weak Cash ConversionA 42% cash conversion rate in H1 and declining operating cash flow in 2025 show a disconnect between accounting profits and cash generation. Persistent working-capital or timing headwinds could constrain capital returns, M&A flexibility and investment despite strong reported earnings, making cash quality a structural watch item.
Input Cost & Supply RiskOngoing input-cost inflation, commodity volatility and regional supply disruptions (Middle East plant closure examples) create persistent margin pressure and operational risk. If these factors endure, they can erode margins and require structural sourcing, pricing or capital changes to restore prior profitability levels.
Category Competitive PressureA decline in Household Care and sustained heavy promotional activity in Auto Dish highlight structural competitive and pricing pressures in key categories. Prolonged promo wars can compress margins, slow premiumization and force trade-offs between volume share and long-term profitability, challenging margin sustainability.
Reckitt News
RBN FAQ
What was Reckitt’s price range in the past 12 months?
Reckitt lowest stock price was $1056.60 and its highest was $1572.05 in the past 12 months.
What is Reckitt’s market cap?
Reckitt’s market cap is $747.77B.
When is Reckitt’s upcoming earnings report date?
Reckitt’s upcoming earnings report date is Mar 03, 2027 which is in 199 days.
How were Reckitt’s earnings last quarter?
Reckitt released its earnings results on Jul 29, 2026. The company reported $23.536 earnings per share for the quarter, missing the consensus estimate of $33.081 by -$9.545.
Is Reckitt overvalued?
According to Wall Street analysts Reckitt’s price is currently Undervalued.
Does Reckitt pay dividends?
Reckitt does not currently pay dividends.
What is Reckitt’s EPS estimate?
Reckitt’s EPS estimate is 44.49.
How many shares outstanding does Reckitt have?
Reckitt has 635,007,200 shares outstanding.
What happened to Reckitt’s price movement after its last earnings report?
Reckitt reported an EPS of $23.536 in its last earnings report, missing expectations of $33.081. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Reckitt?
Currently, no hedge funds are holding shares in MX:RBN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Reckitt Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$1,434.16 (33.60% Upside)
$1,434.16 (33.60% Upside)
Blogger Sentiment
Bullish
MX:RBN Sentiment 100%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth $5.7M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-7.21%
12-Months-Change
Fundamentals
Return on Equity
6.35%
Trailing 12-Months
Asset Growth
-0.78%
Trailing 12-Months
Company Description
Reckitt
Reckitt Benckiser Group Plc engages in the manufacture and trade of consumer brand products including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, and Woolite. It operates through the following segments: Hygiene, Health, and Nutrition. The company was founded by Isaac Reckitt in 1840 and is headquartered in Slough, the United Kingdom.
RBN Stock 12 Month Forecast
Average Price Target
$1,434.16
▲(33.60% Upside)